lutein has been researched along with Carcinoma, Hepatocellular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, R; Maradagi, T; Ponesakki, G | 1 |
| Chen, HY; Chen, JY; Hu, ML; Yang, CM; Yueh, TC | 1 |
| Gao, YT; Ong, CN; Ross, RK; Yu, MC; Yuan, JM | 1 |
3 other study(ies) available for lutein and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Hyperglycaemia-induced human hepatocellular carcinoma (HepG2) cell proliferation through ROS-mediated P38 activation is effectively inhibited by a xanthophyll carotenoid, lutein.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Hep G2 Cells; Humans; Hyperglycemia; Liver Neoplasms; Lutein; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Xanthophylls | 2022 |
Multicarotenoids at Physiological Levels Inhibit Metastasis in Human Hepatocarcinoma SK-Hep-1 Cells.
Topics: beta Carotene; Carcinoma, Hepatocellular; Carotenoids; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cryptoxanthins; Humans; Lutein; Lycopene; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Metastasis; rac1 GTP-Binding Protein; rho-Associated Kinases; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2 | 2015 |
Prediagnostic level of serum retinol in relation to reduced risk of hepatocellular carcinoma.
Topics: beta Carotene; Carcinoma, Hepatocellular; Carotenoids; Case-Control Studies; China; Cryptoxanthins; Humans; Incidence; Liver Neoplasms; Logistic Models; Lutein; Lycopene; Male; Micronutrients; Middle Aged; Odds Ratio; Prospective Studies; Risk Assessment; Risk Factors; Selenium; Tocopherols; Vitamin A; Xanthophylls; Zeaxanthins | 2006 |